Skip to main content
. 2017 Jan 18;8(8):13253–13263. doi: 10.18632/oncotarget.14710

Figure 5. miR-625 inhibits tumorigenicity of malignant melanoma cells in vivo.

Figure 5

A-C. Photographs of tumors derived for pSilencer-miR-Control or pSilencer-miR-625 stably transfected A375 cells in nude mice. D. Growth kinetics of tumors in nude mice. Tumor diameters were measured every 7 days (*P < 0.05). E. Average weight of tumors in nude mice. Means ± S.D. were shown (*P < 0.05).